EUDA (EUDA Health Holdings Limited Ordinary Shares) Stock Analysis - AI Report

EUDA Health Holdings Limited Ordinary Shares (EUDA) is a publicly traded Healthcare sector company. As of May 21, 2026, EUDA trades at $18.00 with a market cap of $36.47M and a P/E ratio of -8.79. EUDA moved +6.57% today. Year to date, EUDA is -60.70%; over the trailing twelve months it is -76.83%. Its 52-week range spans $5.26 to $126.00. Analyst consensus is buy with an average price target of $2.75. Rallies surfaces EUDA's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What is the AI research view on EUDA?

Rallies AI research for EUDA combines live market data, fundamentals, news, analyst context, hedge fund holdings, politician trades, insider activity, and risk factors into a ticker-specific research workflow.

EUDA Key Metrics

Key financial metrics for EUDA
MetricValue
Price$18.00
Market Cap$36.47M
P/E Ratio-8.79
EPS$-2.07
Dividend Yield0.00%
52-Week High$126.00
52-Week Low$5.26
Volume956
Avg Volume0
Revenue (TTM)$9.84M
Net Income$-24.95M
Gross Margin34.09%

Latest EUDA News

EUDA Analyst Consensus

1 analysts cover EUDA: 0 strong buy, 1 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $2.75.

Common questions about EUDA

What is the AI research view on EUDA?
Rallies AI research for EUDA combines live market data, fundamentals, news, analyst context, hedge fund holdings, politician trades, insider activity, and risk factors into a ticker-specific research workflow.
What data powers the Rallies AI report for EUDA?
Rallies AI research for EUDA combines live market data, financials, news, analyst context, hedge fund ownership, politician disclosures, insider activity, and risk factors.
Is EUDA research on Rallies investment advice?
No. Rallies provides research, data, and educational context for EUDA. It does not provide personalized investment advice.
EUDA

EUDA